Generic weight loss drugs could alleviate shortages, says BGMA

Although the British Generic Manufacturers Association anticipates at least four companies receiving UK marketing authorisations for type 2 diabetes and obesity, it remains unclear how many will be rolled out immediately.
Woman injects weight loss pen in her arm
Liraglutide, a glucagon-like peptide-1 receptor agonist, helps treat type 2 diabetes mellitus and obesity

Shutterstock.com

The British Generic Manufacturers Association (BGMA) has said that the “first wave” of generic weight loss medicines could be made available in the UK, providing “greater choice and better availability for physicians in managing patients’ weight loss needs”.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated